Immunic, Inc. (IMUX)
8.15
+0.59
(+7.80%)
USD |
NASDAQ |
Oct 09, 10:09
Immunic Price to Book Value : 0.8716 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 0.8085 |
| October 07, 2026 | 0.816 |
| October 06, 2026 | 0.8363 |
| October 05, 2026 | 0.8631 |
| October 02, 2026 | 0.8513 |
| October 01, 2026 | 0.924 |
| September 30, 2026 | 0.9946 |
| September 29, 2026 | 0.9529 |
| September 28, 2026 | 1.017 |
| September 25, 2026 | 0.9994 |
| September 24, 2026 | 0.9968 |
| September 23, 2026 | 1.002 |
| September 22, 2026 | 1.159 |
| September 21, 2026 | 1.158 |
| September 18, 2026 | 1.136 |
| September 17, 2026 | 1.107 |
| September 16, 2026 | 1.082 |
| September 15, 2026 | 1.109 |
| September 14, 2026 | 1.201 |
| September 11, 2026 | 1.221 |
| September 10, 2026 | 1.266 |
| September 09, 2026 | 1.304 |
| September 08, 2026 | 1.362 |
| September 04, 2026 | 1.402 |
| September 03, 2026 | 1.365 |
| Date | Value |
|---|---|
| September 02, 2026 | 1.523 |
| September 01, 2026 | 1.559 |
| August 31, 2026 | 1.690 |
| August 28, 2026 | 1.647 |
| August 27, 2026 | 1.743 |
| August 26, 2026 | 1.764 |
| August 25, 2026 | 1.756 |
| August 24, 2026 | 1.760 |
| August 21, 2026 | 1.765 |
| August 20, 2026 | 1.722 |
| August 19, 2026 | 1.759 |
| August 18, 2026 | 1.807 |
| August 17, 2026 | 1.714 |
| August 14, 2026 | 1.718 |
| August 13, 2026 | 1.773 |
| August 12, 2026 | 1.704 |
| August 11, 2026 | 1.656 |
| August 10, 2026 | 1.508 |
| August 07, 2026 | 1.529 |
| August 06, 2026 | 1.555 |
| August 05, 2026 | 1.498 |
| August 04, 2026 | 1.503 |
| August 03, 2026 | 1.508 |
| July 31, 2026 | 1.494 |
| July 30, 2026 | 1.496 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.627 |
| Sionna Therapeutics, Inc. | 0.8650 |
| Alnylam Pharmaceuticals, Inc. | 22.88 |
| Savara, Inc. | 7.020 |
| Vericel Corp. | 5.666 |
Price to Book Value Related Metrics
| Price | 8.15 |
| Earnings Yield | -58.97% |
| Market Cap | 111.20M |